MedTrace Logo

Presence of Nanoparticles in the Amniotic Fluid

NCT02720887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2018-09-28

No results posted yet for this study

Summary

The nanoparticles (NP) are defined as particles whose size is no greater than 100 nanometers. However, their impact on health remains little evaluated.

Placental transfer of NP has been proven in many studies in vitro and in vivo in animals, and toxicity in the fetus has been studied in many animals. The investigators seem interesting at first to establish the mineralogical load in the amniotic fluid in humans.

The first objective of this study is to determine the mineralogical NP load, quantity and composition, in the amniotic fluid in pregnant women.

Conditions

  • Intrauterine Disorder

Interventions

PROCEDURE

Nanoparticles load

Pregnant women will have a sampling of amniotic fluid to measure load and composition of nanoparticles.

Sponsors & Collaborators

  • SAINBIOSE

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Celine CHAULEUR, PhD · CHU SAINT-ETIENNE

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2018-04-13
Completion
2018-04-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02720887 on ClinicalTrials.gov